CANF

Can-Fite BioPharma Ltd. CANF

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode CANF ARDS BLRX ENLV OPGN PLUR PPBT
6M -67.24 % 1 300.00 % 40.00 % 22.56 % -100.00 % 17.24 % -75.47 %
YTD -71.26 % 1 300.00 % -62.33 % -11.29 % -99.98 % 3.43 % -86.64 %
1Y -79.59 % 1 300.00 % -79.10 % -24.14 % -99.99 % -9.71 % -85.04 %
3Y -93.03 % -99.86 % -89.08 % -74.36 % -100.00 % -25.36 % -98.46 %
5Y -97.26 % -99.98 % -94.13 % -92.07 % -100.00 % -94.79 % -99.30 %
10Y -99.92 % -99.99 % -99.57 % -99.51 % -100.00 % -96.82 % -99.90 %
From the beginning -99.94 % -99.99 % -99.89 % -99.67 % -100.00 % -99.98 % -99.90 %

Dividend